Exco Technologies Limited Announces Normal Course Issuer Bid
TORONTO, Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Exco Technologies Limited ( TSX: XTC ) ( "Exco" or the "Company" ) today announced that the Toronto Stock Exchange ( "TSX" ) has approved the Company's normal course issuer bid ( "NCIB" ) . Under the NCIB, Exco has the right to purchase for ...
Tesla Files Fresh Lawsuit Against Matthews After Court Defeat - Tesla ( NASDAQ:TSLA ) , Matthews International ( NASDAQ:MATW )
U.S. court denies Tesla's request to block Matthews' DBE sales. Tesla files yet another lawsuit in Federal Court against Matthews. Matthews plans to defend this additional lawsuit while pursuing in parallel claims against Tesla for its wrongful conduct.
Lottery.com Announces Global Advisory Board to Support Growth Initiatives
FORT WORTH, Texas, Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Lottery.com Inc. ( Nasdaq: LTRY, LTRYW ) ( "Lottery.com" or the "Company" ) , a leading technology company in digital lottery and sports entertainment, announces the establishment of a global advisory board ( the "Advisory Board" ) to ...
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week - GSK ( NYSE:GSK )
The FDA approved GSK's Penmenvy vaccine for ages 10-25, targeting five major meningococcal serogroups: A, B, C, W, and Y. Phase 3 trials with 4,800 participants showed the vaccine has a safety profile consistent with GSK's existing meningococcal vaccines.
Jim Simons' Renaissance Technologies Makes AI Moves: Sells Big Tech, Buys Chinese Stocks, Robinhood In Q4 - Alibaba Gr Hldgs ( NYSE:BABA ) , Alphabet ( NASDAQ:GOOGL )
Late investor Jim Simons' fund Renaissance Technologies LLC made some significant changes within its artificial intelligence bets during the fourth quarter of 2024. The 13F SEC filings reveal that Renaissance increased its stake in a few Asia-based AI companies during the quarter.
Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop
The U.S. prebiotic soda category has more than doubled over the last five years.
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® ( aflibercept )
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical ...
Hesai Group to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 10, 2025
- Earnings Call Scheduled for 9:00 PM ET on March 10, 2025 - - Earnings Call Scheduled for 9:00 PM ET on March ...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® ( aflibercept ) - Alvotech ( NASDAQ:ALVO )
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ALVO, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. ( ...
